- Status:
- Do Not Prescribe (DNP), Red
- Decision Date:
- October 2019
Comments
RED: NICE TA628: Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer (Decision date - June 2020)
DNP: NICE TA909: Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer. (Decision date - August 2023)
NHSE commissioned
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again